Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Department of Justice
Mallinckrodt
Cantor Fitzgerald
Medtronic
Chinese Patent Office
Healthtrust
Julphar
Express Scripts

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077094

« Back to Dashboard

NDA 077094 describes RIBAVIRIN, which is a drug marketed by Casi Pharms Inc, Teva, Zydus Pharms Usa, Navinta Llc, Aurobindo Pharma, Kadmon Pharms Llc, Sandoz, and Sandoz Inc, and is included in ten NDAs. It is available from eleven suppliers. Additional details are available on the RIBAVIRIN profile page.

The generic ingredient in RIBAVIRIN is ribavirin. There are fifteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ribavirin profile page.
Summary for 077094
Tradename:RIBAVIRIN
Applicant:Zydus Pharms Usa
Ingredient:ribavirin
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 077094
Ingredient-typeNucleoside Analog
Medical Subject Heading (MeSH) Categories for 077094
Suppliers and Packaging for NDA: 077094
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIBAVIRIN ribavirin TABLET;ORAL 077094 ANDA Cadila Healthcare Limited 65841-046 N 65841-046-03
RIBAVIRIN ribavirin TABLET;ORAL 077094 ANDA Cadila Healthcare Limited 65841-046 N 65841-046-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Dec 5, 2005TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength400MG
Approval Date:Mar 16, 2007TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength600MG
Approval Date:Mar 16, 2007TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cerilliant
Moodys
QuintilesIMS
Fuji
Harvard Business School
Federal Trade Commission
Medtronic
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.